Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0035869 | ciliary transition zone | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IH07
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0030030 | cell projection organization | 4 | 1 |
GO:0030031 | cell projection assembly | 5 | 1 |
GO:0044782 | cilium organization | 5 | 1 |
GO:0060271 | cilium assembly | 6 | 1 |
GO:0070925 | organelle assembly | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 1 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 1 |
GO:1905515 | non-motile cilium assembly | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
DOC_CYCLIN_yCln2_LP_2 | 42 | 48 | PF00134 | 0.361 |
DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.361 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.533 |
LIG_BRCT_BRCA1_1 | 11 | 15 | PF00533 | 0.564 |
LIG_EVH1_1 | 44 | 48 | PF00568 | 0.342 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.394 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.542 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.310 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.495 |
LIG_LIR_Gen_1 | 106 | 115 | PF02991 | 0.292 |
LIG_LIR_Gen_1 | 58 | 67 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 58 | 62 | PF02991 | 0.344 |
LIG_PCNA_PIPBox_1 | 53 | 62 | PF02747 | 0.369 |
LIG_Pex14_1 | 103 | 107 | PF04695 | 0.264 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.270 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.294 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.311 |
LIG_SUMO_SIM_anti_2 | 58 | 64 | PF11976 | 0.422 |
LIG_TYR_ITIM | 99 | 104 | PF00017 | 0.419 |
LIG_WRC_WIRS_1 | 56 | 61 | PF05994 | 0.369 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.698 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.670 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.335 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.419 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.477 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.374 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.382 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.711 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.310 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.403 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.340 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.517 |
MOD_PIKK_1 | 131 | 137 | PF00454 | 0.541 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.286 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.313 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.369 |
MOD_SUMO_for_1 | 146 | 149 | PF00179 | 0.698 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.332 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.271 |
TRG_ENDOCYTIC_2 | 119 | 122 | PF00928 | 0.222 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.343 |
TRG_ER_diLys_1 | 157 | 160 | PF00400 | 0.738 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KJD7 | Bodo saltans | 41% | 100% |
A0A1X0P9G7 | Trypanosomatidae | 47% | 89% |
A0A3R7JUI1 | Trypanosoma rangeli | 51% | 95% |
A4IAP0 | Leishmania infantum | 99% | 100% |
C9ZN13 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 95% |
E9B4P0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q3D6 | Leishmania major | 94% | 100% |